model were used to examine the relationship between obesity, total serum IgE, and atopy. Results: We measured the total serum IgE of 155 children. The number of obese and normal weight children with family history of atopic disease who had high level of total serum IgE were 30 and 25 respectively, whereas these children who had normal level of total serum IgE were 6 and 15 respectively [OR ¼ 1.9 (95% CI 0.9-3.9)]. On the other hand, obese and normal weight children without family history of atopic disease who had high level of total serum IgE were 21 and 11 respectively, whereas these children who had normal level of total serum IgE were 18 and 29 respectively [OR ¼ 1.7 (95% CI 1.1-2.7)]. The number of obese and normal weight children without family history of atopic disease who had atopy were 38 and 9 respectively, whereas these children who had non-atopy were 2 and 31 respectively [OR ¼ 13.3 (95% CI 3.5-52)], but there was no relationship between atopy and obesity in group with family history of atopic disease (P ¼ 0.314). Conclusions: There were relationship between high level of total serum IgE and obesity in group with and without family history of atopic disease and also relationship between atopy and obesity in group without family history of atopic disease. Background: The World Allergy Organization in 2011 estimated that 30 to 40% of the world population is now affected by one or more allergic conditions. Since the IgE plays a central role in the expansion and regulation of allergic response that seems the IgE elimination is the best approach in the control of asthma and allergic diseases. Now, an anti-IgE antibody as a drug (Xolair) is available and efficient but is expensive with short half-life. As good and more efficient substitution IgE peptide-based vaccines has been proposed. Methods: In this study, we analyzed all potential antigenic peptides on the constant region of the Ig epsilon chain (Fce). For determination of B cell immunodominant epitope, we used the antibody epitope prediction tools. In continuing candidate peptides were done BlastP to avoid nonspecific antibody reactions with other human proteins in the NCBI database. And then, to preparation of vaccines, peptides were synthesized and conjugated by Tetanus toxoid (TT). To immunogenicity analysis of vaccines, the rats are being immunized with vaccines or TT as control. Results: By Kolaskar and Tongaonkar antigenicity algorithms 20 peptides with putative epitopes were selected. Homologous sequences and also previous studies peptides were excluded, 13 peptides remained that used for vaccine preparation. The produced vaccines are being analyzed for their effect on induction of anti-IgE antibody production. Peptides based on antibody production or not, were divided in 2 groups. Conclusions: Active immunization by IgE peptide based vaccines can be triggering production antibodies against self-IgE that are effective in preventing and control of IgE levels as an important factor in asthma and allergic diseases. 
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Background:
We have identified a family in which 3 of 4 children are affected with significant autoimmunity and immunodeficiency that does not fit any of the known disorders. We have embarked to characterize their defect and describe a completely new disorder. Methods: Whole Exome Sequencing, T and B Cell Immunophenotyping, Radiation Sensitivity, Bacteriophage. Results: The oldest affected child is female with severe polyarticular arthritis (treated with etanercept), eczema, diarrhea, short stature and numerous infections including pneumonia. She is s/p bone marrow transplant using a matched sibling donor, is fully engrafted and doing well. The second affected child was also female and had numerous episodes of pneumonia, bronchiolitis, otitis media and conjunctivitis. She died at 11 months from presumed fulminant CMV hepatitis. The third affected child is male with hypothyroidism, chronic diarrhea, alopecia totalis, eczema, multiple food allergies, reactive airway disease and short stature. All had normal CD41 and CD81 T cell and NK cell numbers but marked B cell lymphopenia. T cell immunophenotyping demonstrated a modest decrease in effector memory T cells. Mitogens were normal. B cell immunophenotyping demonstrated a dramatic block in B cell development at the transition from immature to mature B cells suggesting a defect in immunoglobulin gene rearrangement. All affected patients were hypogammaglobulinemic. Immunization with bacteriophage FX174 to more thoroughly evaluate humoral immune responses demonstrated a poor immunoglobulin response with only modest amplification and markedly decreased immunoglobulin class switching. Radiation sensitivity testing using skin fibroblasts was performed and demonstrated an intermediate radiation sensitivity. Sequencing of the RAG1, RAG2, and Artemis genes was normal. Evaluation via western blotting of other components of the DNA repair machinery that lead to defective immunoglobulin gene rearrangement and radiation sensitivity was normal. Conclusions: The overall clinical and laboratory picture of severe autoimmunity with a T1B-NK1 phenotype is unusual and does not fit any known immune defect. The CMV susceptibility suggests that even though T cell numbers and proliferation are normal, there may be a subtle defect in T cell function. We are currently in the process of whole exome sequencing and optimistic we will find a novel defect in DNA repair. 2 Immunology Center, Georgetown University Medical Center, Washington, DC. Background: Autoimmunity is present in several patients that have allergy and immunodeficiency; however there are few reports that correlate these 3 immunological problems. Our objective was to study the association of these 3 problems where the deregulation of the T reg cells has a roll in triggering a chronic inflammation and the clinical expression. Methods: We included 8 patients with symptoms of autoimmune disease, such as autoimmune hypothyroidism, dermatomiositis, systemic vasculitis, autoimmune uveitis, Wegener s granulomatosis, antiphospholipid syndrome, Kawasaki s disease and SLE with allergic disease and T and B lymphocytes immunodeficiency. We did the clinical history, skin test and also immunological evaluation with immunoglobulins, IgG subclasses, T lymphocytes absolute numbers and specific antibodies, all of them had diagnosis of allergy, with immunodeficiency and autoimmune disease. Results: There were included 8 patients, with moderate to severe allergy and recurrent infections, from 3 to 66 years of age, 1 child (12.5%) and 7 adults (87.5%), 7 women (93.3%), 1 men (12.5%) with allergic rhinitis 8 (100%), combination of allergic rhinitis and other allergic disease 2 (25%), asthma 1 (12.5%), atopic dermatitis 1 (12.5%). Also all the 8 patients had humoral, cellular immunodeficiency and autoimmune problems, 7 of them received
